Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Coya, Dr Reddy’s sign pact to develop and market COYA 302 for treatment of ALS
Coya retains the right to commercialise COYA 302 for patients with amyotrophic lateral sclerosis (ALS) in Japan, Mexico, and each…
India pharma tech’s next big opportunity lies in sales and marketing stack: Bessemer Venture…
Increasing adoption of technology by healthcare professionals, data centric mindset of modern pharma marketing leaders, and…
Chandigarh Calling!
Pharma experts and leaders unite to unravel opportunities for India Pharma Inc and explore Chandigarh's potential to fuel India's…
Future-proofing the pharma cold chain
As India's pharma sector undergoes a transformative shift, an agile and scalable cold chain characterised by innovative…
Wockhardt completes Phase 3 pneumonia study of macrolide antibiotic Nafithromycin WCK 4873
The results of the study showed that an ultrashort course of three-day treatment with Nafithromycin is as effective as seven-day…
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US
Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline
The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 euros ($2.15-$5.38 billion) in peak sales…
Ceremorphic demonstrates BioCompDiscoverX supercomputing platform for accelerated drug discovery
The BioCompDiscoverX will be available in Q3 2024 and will include technologies incorporated in its proprietary silicon device
IPC issues alert against adverse reactions of painkiller Meftal
The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of…
Fortifying Brand India Pharma
Lessons and insights on measures and approaches to drive innovation, quality and growth in India's pharma sector from industry…